| 2024/05/09 22:00:00 | |
|---|---|
| Price | |
| 1.03 USD | |
| Difference | 37.44% (0.28) |
General attributes
| ISIN | US81750R1023 |
| Symbol | MCRB |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 145 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 1.03 USD (700) |
| Ask (Ask size) | 1.05 USD (400) |
| Open | 0.77 USD |
| High | 1.10 USD |
| Low | 0.7606 USD |
| Close (prev. day) | 0.7494 USD |
| VWAP | 0.986665 USD |
| Volume (pcs) | 16,647,222 |
| Trading volume | 16,426,221.41 |
| Number of trades | 27,512 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/09 22:00:00 | |
|---|---|
| Price | |
| 1.03 USD | |
| Difference | 37.44% (0.28) |
General attributes
| ISIN | US81750R1023 |
| Symbol | MCRB |
| Exchange | Nasdaq |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 145 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 1.03 USD (700) |
| Ask (Ask size) | 1.05 USD (400) |
| Open | 0.77 USD |
| High | 1.10 USD |
| Low | 0.7606 USD |
| Close (prev. day) | 0.7494 USD |
| VWAP | 0.986665 USD |
| Volume (pcs) | 16,647,222 |
| Trading volume | 16,426,221.41 |
| Number of trades | 27,512 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -27.94% | -86.52% | -96.38% |
| Perf (abs.) | -0.29 | -4.81 | -19.98 |
| Beta | 2.07 | 0.82 | 1.27 |
| Volatility | 125.69 | 116.58 | 109.80 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 1.06 USD (7,163,649) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.79 USD (5,342,907) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.01 USD (5,000,673) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.37 USD (3,767,690) |
| YTD High | date | 2.05 USD (2024/01/09) |
| YTD Low | date | 0.54 USD (2024/04/19) |
| 52 Weeks High | date | 6.26 USD (2023/06/14) |
| 52 Weeks Low | date | 0.54 USD (2024/04/19) |
All listings for SERES THERAPEUTICS INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/09 | 22:26 | 0.951 EUR | 0.01 | 4 |
| Stuttgart | 2024/05/09 | 18:35 | 0.9278 EUR | 0.00 | 5 |
| Nasdaq | 2024/05/09 | 22:00 | 1.03 USD | 16.43 | 27,512 |
| Frankfurt | 2024/05/09 | 08:45 | 0.6832 EUR | 0.00 | 2 |
| Duesseldorf | 2024/05/09 | 19:56 | 0.884 EUR | 0.00 | 6 |
| Berlin | 2024/05/09 | 08:04 | 0.6546 EUR | 0.00 | 1 |
Company Profile
| - |
Members of Management Board
| Stephen Berenson | Chairman of Board of Directors |
| Claire Fraser-Liggett | Member of Board of Directors |
| Dennis Ausiello | Member of Board of Directors |
| Willard Dere | Member of Board of Directors |
| Kurt Graves | Member of Board of Directors |
| Paul Biondi | Member of Board of Directors |
| Richard Kender | Member of Board of Directors |